Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

Naeem Bhojani; Claudio Jeldres; Jean Jacques Patard; Paul Perrotte; Nazareno Suardi; Georg Hutterer; François Patenaude; Stéphane Oudard; Pierre I. Karakiewicz

doi:10.1016/j.eururo.2007.11.037

Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

Naeem Bhojani, Claudio Jeldres, Jean Jacques Patard, Paul Perrotte, Nazareno Suardi, Georg Hutterer, François Patenaude, Stéphane Oudard, Pierre I. Karakiewicz

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To provide a systematic review of the side effects associated with sorafenib, sunitinib, and temsirolimus and to provide an outline of possible preventive or therapeutic measures. Methods: We performed a PubMed-based systematic review of side effects associated with the three agents and relied on product monographs and prescribing information to provide an outline of treatments aimed at reducing these toxicities. Results: Side effects range from

Original language	English
Pages (from-to)	917-930
Number of pages	14
Journal	European Urology
Volume	53
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2007.11.037
Publication status	Published - May 2008

Keywords

Side effects
Sorafenib
Sunitinib
Temsirolimus

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2007.11.037

Cite this

Bhojani, N., Jeldres, C., Patard, J. J., Perrotte, P., Suardi, N., Hutterer, G., Patenaude, F., Oudard, S., & Karakiewicz, P. I. (2008). Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma. European Urology, 53(5), 917-930. https://doi.org/10.1016/j.eururo.2007.11.037

Bhojani, N, Jeldres, C, Patard, JJ, Perrotte, P, Suardi, N, Hutterer, G, Patenaude, F, Oudard, S & Karakiewicz, PI 2008, 'Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma', European Urology, vol. 53, no. 5, pp. 917-930. https://doi.org/10.1016/j.eururo.2007.11.037

@article{8f621c4ab9c541968262b73b1a069a3f,

title = "Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma",

abstract = "Objective: To provide a systematic review of the side effects associated with sorafenib, sunitinib, and temsirolimus and to provide an outline of possible preventive or therapeutic measures. Methods: We performed a PubMed-based systematic review of side effects associated with the three agents and relied on product monographs and prescribing information to provide an outline of treatments aimed at reducing these toxicities. Results: Side effects range from ",

keywords = "Side effects, Sorafenib, Sunitinib, Temsirolimus",

author = "Naeem Bhojani and Claudio Jeldres and Patard, {Jean Jacques} and Paul Perrotte and Nazareno Suardi and Georg Hutterer and Fran{\c c}ois Patenaude and St{\'e}phane Oudard and Karakiewicz, {Pierre I.}",

year = "2008",

month = may,

doi = "10.1016/j.eururo.2007.11.037",

language = "English",

volume = "53",

pages = "917--930",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "5",

}

TY - JOUR

T1 - Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

AU - Bhojani, Naeem

AU - Jeldres, Claudio

AU - Patard, Jean Jacques

AU - Perrotte, Paul

AU - Suardi, Nazareno

AU - Hutterer, Georg

AU - Patenaude, François

AU - Oudard, Stéphane

AU - Karakiewicz, Pierre I.

PY - 2008/5

Y1 - 2008/5

N2 - Objective: To provide a systematic review of the side effects associated with sorafenib, sunitinib, and temsirolimus and to provide an outline of possible preventive or therapeutic measures. Methods: We performed a PubMed-based systematic review of side effects associated with the three agents and relied on product monographs and prescribing information to provide an outline of treatments aimed at reducing these toxicities. Results: Side effects range from

AB - Objective: To provide a systematic review of the side effects associated with sorafenib, sunitinib, and temsirolimus and to provide an outline of possible preventive or therapeutic measures. Methods: We performed a PubMed-based systematic review of side effects associated with the three agents and relied on product monographs and prescribing information to provide an outline of treatments aimed at reducing these toxicities. Results: Side effects range from

KW - Side effects

KW - Sorafenib

KW - Sunitinib

KW - Temsirolimus

UR - http://www.scopus.com/inward/record.url?scp=41149108218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149108218&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2007.11.037

DO - 10.1016/j.eururo.2007.11.037

M3 - Article

C2 - 18054825

AN - SCOPUS:41149108218

VL - 53

SP - 917

EP - 930

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -

Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this